Dow Giant J&J Beats Views, Guides Higher

Johnson & Johnson (JNJ) on Wednesday reported adjusted earnings of $2.48 per share on $23.31 billion in sales for its second quarter. In response, JNJ stock rose slightly.


On average, analysts polled by FactSet expected Johnson & Johnson to earn $2.29 per share on $22.49 billion in sales. In the year-earlier period, J&J earned $1.67 a share and reported $18.34 billion in sales.

For the year, the Dow Jones health care giant guided to adjusted EPS of $9.50-$9.60 from $9.42-$9.57. It sees sales of $92.5 billion to $93.3 billion. Analysts called for adjusted profit of $9.56 per share and $92.37 billion in sales.

In premarket trading on the stock market today, JNJ stock rose about 1% to 170. Shares are forming a flat base with a buy point at 173.75, according to

More to follow.

Follow Allison Gatlin on Twitter at @IBD_AGatlin.


Drug Stocks Pop On Reports Of $26 Billion Settlement In Opioid Fight

IBD Stock Of The Day Elanco Flashes Possible Buy Signal As Pet Trends Bolster Shares

Get Stock Ideas From IBD Experts Each Morning Before The Open

Want More IBD Insights? Subscribe To Our Investing Podcast!

Learn How To Time The Market With IBD’s ETF Market Strategy

Most Related Links :
todayprimenews Governmental News Finance News

Source link

Back to top button